default author photo

Katy Rezvani

The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy

1901 East Road, Unit 1950

Houston, TX 77030

United States

SCHOLARLY PAPERS

3

DOWNLOADS

289

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Ponatinib and Blinatumomab for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Single-Arm, Phase 2 Trial

Number of pages: 28 Posted: 27 Apr 2022
University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Biostatistics, University of Texas at Houston - Department of Leukemia, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia and University of Texas at Houston - Department of Leukemia
Downloads 222 (343,660)

Abstract:

Loading...

blinatumomab, ponatinib, Philadelphia Chromosome, bcr-abl1, ALL

2.

Molecular Mechanisms of snoRNA-IL-15 Crosstalk in Adipocyte Lipolysis and NK Cell Rejuvenation

Number of pages: 70 Posted: 29 Sep 2022
University of Texas at Houston - Department of Molecular and Cellular Oncology, University of Texas at Houston - Department of Molecular and Cellular Oncology, University of Texas at Houston - Department of Molecular and Cellular Oncology, Texas A&M University - Center for Epigenetics and Disease Prevention, University of Texas at Houston - Department of Molecular and Cellular Oncology, University of Texas at Houston - Department of Molecular and Cellular Oncology, University of Texas at Houston - Department of Molecular and Cellular Oncology, Texas A&M University - Center for Epigenetics and Disease Prevention, Texas A&M University - Center for Epigenetics and Disease Prevention, University of Texas at Houston - Department of Molecular and Cellular Oncology, University of Texas at Houston - Department of Molecular and Cellular Oncology, University of Texas at Houston - Department of Molecular and Cellular Oncology, University of Texas at Houston - Department of Molecular and Cellular Oncology, University of Texas at Houston - Division of Surgery, University of Texas at Houston - Division of Pathology and Laboratory Medicine, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Molecular and Cellular Oncology, University of Texas at Houston - Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, China Medical University, Graduate Institute of Biomedical Sciences, University of Texas at Houston - UT Health Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Experimental Radiation Oncology, Texas A&M University - Center for Epigenetics and Disease Prevention, University of Texas at Houston - Department of Molecular and Cellular Oncology and University of Texas at Houston - Department of Molecular and Cellular Oncology
Downloads 35 (1,249,711)

Abstract:

Loading...

Small Nucleoli RNA, Interleukin-15, Obesity, Adipocyte, Nature Killer cells, Lipase, Autophagy

3.

Generation of Glucocorticoid Resistant SARS-CoV-2 T-Cells for Adoptive Cell Therapy

Number of pages: 48 Posted: 20 Oct 2020
The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center - Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center - Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas Medical Branch-Galveston - Department of Internal Medicine, University of Texas Medical Branch-Galveston - Department of Pathology, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Leukemia, The University of Texas MD Anderson Cancer Center - Department of Leukemia, The University of Texas MD Anderson Cancer Center - Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center - Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - MD Anderson Cancer Center and The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy
Downloads 32 (1,290,922)

Abstract:

Loading...